Disclosures for "Stem Cell-Derived Spinal Cord Organoid Model: Temporal and Cell-Specific Analysis of Molecular Effects of a Risdiplam Analogue"
-
Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
-
Author has nothing to disclose
-
Francesca Beatrice has nothing to disclose.
-
Dr. Cordiglieri has nothing to disclose.
-
Matteo Miotto has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Meneri has nothing to disclose.
-
Dr. Gagliardi has nothing to disclose.
-
Author has nothing to disclose
-
Giacomo Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Giacomo Comi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
-
Linda Ottoboni has nothing to disclose.